Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK industry agrees flexible five-year price plan after cuts – update

This article was originally published in Scrip

Executive Summary

The UK pharmaceutical industry and the government have reached agreement on a new five-year pharmaceutical price regulation scheme (PPRS) that revises rather than rewrites the system that has governed drug pricing in the UK for 50 years. When the government announced last year that it was scrapping the PPRS, many in industry feared a radical overhaul, but the version mostly finalised this week retains the principal elements of the original scheme.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC031636

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel